Spotlights

Prof. Matthew Johnson | Johns Hopkins University

Read the Interview

Dr. Robin Carhart-Harris | Scientific Advisory Board, Tryp Therapeutics

Read the Interview

Greg McKee | CEO, Tryp Therapeutics

Read the Interview

Jody Aufrichtig | Co-Founder, President and CEO, The Psyence Group

Read the Interview

Srinivas Rao, MD, Ph.D. | Chief Scientific Officer, Atai Life Sciences

Read the Interview

Alex Speiser | COO, Orthogonal Thinker

Read the Interview

Dr. James Gilligan | President and Chief Scientific Officer, Tryp Therapeutics

Read the Interview

Garyn Angel | Founder & CEO, Magical Brands

Read the Interview

Dr. Robin Carhart-Harris | Center for Psychedelic Research, Imperial College

Read the Interview

Doug Drysdale | CEO, Cybin Corp

Read the Interview

Tom D'orazio | COO, Tryp Therapeutics

Read the Interview

Dr. David E. Nichols | Founding President, Hefter Research Institute

Read the Interview

James Kuo, MD, MBA | Director, Tryp Therapeutics

Read the Interview

Ben Nikolaevsky | CEO, Pure Extracts

Read the Interview
No items found.

Doug Benville | COO, Pure Extracts Corp

Read the Interview

Timothy Ko | CEO, Entheon Biomedical

Read the Interview

Robert Roscow | CSO, Mydecine Innovations Group

Read the Interview

Vic Neufeld | Executive Chairman, Havn Life Sciences

Read the Interview

Professor David Nutt | DMT Stroke Consultant , Algernon Pharmaceuticals

Read the Interview

Gary Leong | Chief Scientific Officer, HAVN Life Sciences

Read the Interview

Jeff Stevens | CEO, Psyched Wellness

Read the Interview

Miri Halperin Wernli | President, MindMed

Read the Interview

Dr. Joseph Tucker | Founder & CEO, MagicMed Industries

Read the Interview

Steve Sadoff | CEO, CannaGlobal

Read the Interview

Dr. Jennifer Miller | Principal Investigator, Tryp Therapeutics

Read the Interview

Lorne Gertner | Chairman, CannaGlobal Wellness

Read the Interview

Kelsey Ramsden | CEO, MINDCURE

Read the Interview

Dr. David Mokler | Havn Life Sciences

Read the Interview

Joseph del Moral | Founder & CEO, Field Trip Health

Read the Interview

Judy Blumstock | CEO & Founder, Diamond Therapeutics

Read the Interview

Dr. Peter Facchini | MagicMed Industries

Read the Interview

Dr Rakesh Jetly | Chief Medical Officer, Mydecine

Read the Interview

Dr. Rick Strassman | DMT Stroke Program Consultant, Algernon Pharmaceuticals

Read the Interview

Dr. Glen Z. Brooks | Medical Director & Founder, New York Ketamine Infusions

Read the Interview

Najla Guthrie | CEO & President, KGK Science

Read the Interview

Adam Halberstadt | UC San Diego

Read the Interview

William Garner, M.D. | Executive Director, Tryp Therapeutics

Read the Interview

Dr. Reid Robison | Chief Medical Officer, Novamind Ventures

Read the Interview

Ben Greenfield | Biohacker and New York Times Best Selling Author

Read the Interview

Dr. Jill Hagel, Chief Technology Officer | MagicMed Industries

Read the Interview

Dr. Ivan Casselman | Chief Psychedelic Officer, Havn Life Sciences

Read the Interview

Professor David Nutt | Board of Directors, Psyched Wellness

Read the Interview

Dr. Evan Wood | Chief Medical Officer, Numinus Inc.

Read the Interview

Dr. Mike Dow | Field Trip Health

Read the Interview

Natalie Dolphin | Director, Marketing, MagicMed Industries

Read the Interview

Dane Stevens | CMO & Director, Optimi Health

Read the Interview

Derrick Welsh | Founder, Psilocin Pharma

Read the Interview

Dr. Marvin Hausman | Chief of Scientific Advisory Board, Nova Mentis

Read the Interview

Dr. Michael Verbora | Field Trip Health

Read the Interview

Paul Austin | Founder, Third Wave

Read the Interview

Nethaji Gallage | CEO & Co-Founder, Octarine Bio

Read the Interview

Dr. Denton Hoyer | Scientific Advisor, Mydecine

Read the Interview

Prof. Dr. Eric Vermetten | Scientific Advisory Board Member, Mydecine Innovations

Read the Interview

Jeff Siegel | Managing Partner, JLS Fund

Read the Interview

Irie Selkirk | Co-Founder, Rise Wellness Retreat

Read the Interview

Evan Levine | Chairman & CEO, PsyBio Therapeutics

Read the Interview

Jerry March | COO, New York Ketamine Infusions

Read the Interview

Ben Lightburn | CEO, Filament Health

Read the Interview

Larry Norder | VP Manufacturing, Tryp Therapeutics

Read the Interview

Maghsoud Dariani | Chief Science Officer, Lobe Sciences

Read the Interview

Nick Milne | Co-Founder and CSO at Octarine Bio

Read the Interview

Rob Tessarolo | President & CEO, NeonMind Biosciences

Read the Interview

Dr. Carl Laird Birmingham | Advisory board & Consultant, NeonMind Biosciences

Read the Interview

Joseph Tucker | CEO, MagicMed Industries

Read the Interview

JJ Wilson | Chairman of the Board, Optimi Health

Read the Interview

Spencer Hawkswell | CEO of TheraPsil

Read the Interview

Douglas K. Gordon | CEO, Silo Wellness

Read the Interview

Payton Nyquvest | CEO, Numinus

Read the Interview

Ronan Levy | Field Trip Health

Read the Interview

Paul Glavine | Co-Founder & Chief Growth Officer, Cybin Corp

Read the Interview

Brett Greene | Chief Innovations Officer, Cybin Inc.

Read the Interview

JR Rahn | MindMed

Read the Interview

Roger McIntyre, M.D. | CEO, Champignon Brands

Read the Interview

David Harder | Founder & Co-CEO, Atma Journey Centers

Read the Interview